BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript
BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.11.
Source: insidermonkey.com
📰 Morph Access Innovations News
Morph Access Innovations News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Morph Access Innovations. Real-time updates on events, politics, business and more.
BioCardia : Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results -March 27, 2024 at 01:30 pm EDT
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results March 27, 2024 BioCardia®, Inc. [Nasdaq: BCDA], a developer of...
United States Finkelstein Schoenfeld Peter Altman Device Agency Medicaid Services Exchange Commission On
Source: marketscreener.com